Stereotaxis has launched the Synchrony system for cath laboratories after receiving 510(k) clearance from the US Food and Drug Administration (FDA).
The system is designed to advance digital capabilities in interventional cath labs.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It introduces a 55in 4K ultra-high-definition display that consolidates control and viewing of disparate systems in the lab and features customisable layouts, an intuitive user interface, and improved workflow.
Synchrony delivers full-fidelity video streams with ultra-low latency for clear visualisation and is structured to support future technologies and guard against obsolescence.
The system is offered alongside SynX, a cloud-based application compliant with Health Insurance Portability and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR) standards, enabling secure remote connectivity, recording, monitoring, and collaboration within the cath lab.
Both Synchrony and SynX have been developed as platforms for future innovations, enabling integration of automation, AI, applications, and enhanced clinical insights.
Stereotaxis chairman and CEO David Fischel said: “Synchrony and SynX are central to our digital surgery efforts to modernise the interventional lab with enhanced workflow, remote connectivity, and smart AI capabilities.
“The technology improves the robotic cockpit and will be critical in supporting robotic efforts for remote long-distance procedures and automated catheter navigation. The opportunity is much broader than robotic labs, as we believe all cath labs stand to benefit from improved workflow, connectivity, and collaboration.”
Earlier this year, Stereotaxis received FDA approval for its MAGiC ablation catheter, permitting its use in cardiac ablation procedures.
The catheter is robotically navigated using computer-controlled magnetic fields. It is designed to conduct cardiac ablation procedures that treat various forms of arrhythmia.
